CELG.RT
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
CELG.RT
23 hedge funds and large institutions have $200K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FCM
1
FourWorld Capital Management
New York
|
$69K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$3K |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$7K |
Top Sellers
1 |
1
Citadel Advisors
Miami,
Florida
|
$19K |
2 |
DC
2
Davenport & Co
Richmond,
Virginia
|
$14K |